Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Devi

Showing results (161-170 of 204) with videos related to

Pageof 21
Sort By:
Indian Journal of Medical Microbiology|August 17, 2006
Emergence of sporotrichosis in ManipurK R Devi, M U Devi, T N Singh, et al.
BMC Cancer|September 12, 2012
Differential effects of arsenic trioxide on chemosensitization in human hepatic tumor and stellate cell linesFatima Rangwala, Kevin P Williams, Ginger R Smith, et al.
British Journal of Cancer|April 21, 2011
Targeting GLI1 expression in human inflammatory breast cancer cells enhances apoptosis and attenuates migrationZ I Thomas, W Gibson, J Z Sexton, et al.
Molecular Vision|February 22, 2005
Gln48His is the prevalent myocilin mutation in primary open angle and primary congenital glaucoma phenotypes in IndiaSubhabrata Chakrabarti, Kiranpreet Kaur, Sreelatha Komatireddy, et al.
Translational Oncology|February 27, 2024
XIAP overexpressing inflammatory breast cancer patients have high infiltration of immunosuppressive subsets and increased TNFR1 signaling targetable with BirinapantChristophe Van Berckelaer, Steven Van Laere, Seayoung Lee, et al.
The Canadian Journal of Urology|June 24, 2008
Evaluation of prostate cancer characteristics in four populations worldwideCharnita M Zeigler-Johnson, Hanna Rennert, R Devi Mittal, et al.
Journal of Translational Medicine|September 8, 2007
Long term disease-free survival and T cell and antibody responses in women with high-risk Her2+ breast cancer following vaccination against Her2Michael A Morse, Amy Hobeika, Takuya Osada, et al.
British Journal of Cancer|July 16, 2009
MLH1 expression sensitises ovarian cancer cells to cell death mediated by XIAP inhibitionX Ding, A B Mohd, Z Huang, et al.
Cancer Gene Therapy|October 15, 2011
Depleting regulatory T cells with arginine-rich, cell-penetrating, peptide-conjugated morpholino oligomer targeting FOXP3 inhibits regulatory T-cell functionM A Morse, A Hobeika, D Serra, et al.
NPJ Breast Cancer|June 13, 2022
Adaptive stress response genes associated with breast cancer subtypes and survival outcomes reveal race-related differencesMuthana Al Abo, Larisa Gearhart-Serna, Steven Van Laere, et al.
Pageof 21

Showing results (161-170 of 204) with videos related to

Sort By:
Pageof 21
Indian Journal of Medical Microbiology|August 17, 2006
Emergence of sporotrichosis in ManipurK R Devi, M U Devi, T N Singh, et al.
BMC Cancer|September 12, 2012
Differential effects of arsenic trioxide on chemosensitization in human hepatic tumor and stellate cell linesFatima Rangwala, Kevin P Williams, Ginger R Smith, et al.
British Journal of Cancer|April 21, 2011
Targeting GLI1 expression in human inflammatory breast cancer cells enhances apoptosis and attenuates migrationZ I Thomas, W Gibson, J Z Sexton, et al.
Molecular Vision|February 22, 2005
Gln48His is the prevalent myocilin mutation in primary open angle and primary congenital glaucoma phenotypes in IndiaSubhabrata Chakrabarti, Kiranpreet Kaur, Sreelatha Komatireddy, et al.
Translational Oncology|February 27, 2024
XIAP overexpressing inflammatory breast cancer patients have high infiltration of immunosuppressive subsets and increased TNFR1 signaling targetable with BirinapantChristophe Van Berckelaer, Steven Van Laere, Seayoung Lee, et al.
The Canadian Journal of Urology|June 24, 2008
Evaluation of prostate cancer characteristics in four populations worldwideCharnita M Zeigler-Johnson, Hanna Rennert, R Devi Mittal, et al.
Journal of Translational Medicine|September 8, 2007
Long term disease-free survival and T cell and antibody responses in women with high-risk Her2+ breast cancer following vaccination against Her2Michael A Morse, Amy Hobeika, Takuya Osada, et al.
British Journal of Cancer|July 16, 2009
MLH1 expression sensitises ovarian cancer cells to cell death mediated by XIAP inhibitionX Ding, A B Mohd, Z Huang, et al.
Cancer Gene Therapy|October 15, 2011
Depleting regulatory T cells with arginine-rich, cell-penetrating, peptide-conjugated morpholino oligomer targeting FOXP3 inhibits regulatory T-cell functionM A Morse, A Hobeika, D Serra, et al.
NPJ Breast Cancer|June 13, 2022
Adaptive stress response genes associated with breast cancer subtypes and survival outcomes reveal race-related differencesMuthana Al Abo, Larisa Gearhart-Serna, Steven Van Laere, et al.
Pageof 21